Health Care

Lawmakers looking to lock down a bipartisan infrastructure agreement are considering eliminating a Trump-era rule on Medicare rebates in order to raise revenue, which likely won’t end up hurting the program’s beneficiaries, experts say.

Mark Meadows discusses ongoing infrastructure negotiations and how he expects the plan to play out.

Medicare, the health insurance program for older Americans, would cover dental, vision and hearing under a massive $3.5 trillion budget blueprint reached by Democrats this week that would vastly expand the government-funded social safety net.

U.S. Olympic swimmer Michael Andrew discusses his decision to not get vaccinated before the 2021 Olympics despite a rise in COVID infections in Tokyo.

Merck announced Tuesday that the FDA approved an expanded label for Keytruda to treat patients with certain skin cancer that is not curable by surgery or radiation.

Robert Davis became the new chief executive officer of Merck on Thursday, one day after former CEO Ken Frazier retired.

Agricultural giant Dole Diversified North America, Inc. announced that some cases of its fresh blueberries would be recalled due to potential cyclospora contamination.

The recent approval of a high-price Alzheimer’s drug is raising questions about who will have access to a treatment that could cost Medicare billions of dollars in coming years.

North Carolina is the first state to successfully sue Juul over unfair vaping practices, paving the way for potential other suits.

Sen. Elizabeth Warren, D-Mass., is leading an effort to examine the Food and Drug Administration's (FDA's) recent approval of a drug to treat Alzheimer's.

Eli Lilly announced Thursday that it had received the FDA’s Breakthrough Therapy designation for donanemab, an investigational antibody therapy for Alzheimer’s disease.

23andMe CEO Anne Wojcicki told FOX Business’ Stuart Varney on Monday that her company is focused on changing health care to be more personalized.

Senate Democrats are exploring a sweeping $6 trillion budget reconciliation bill that would include a major expansion of Medicare, a long-time priority of progressive lawmakers.

Lifelong exercise can translate to significant health care savings later on, a study suggests.

A third member of a panel of outside advisers to the U.S. Food and Drug Administration has resigned in protest over the agency's decision to approve Biogen Inc's Alzheimer's disease treatment despite the committee's recommendation against doing so.

The first new Alzheimer’s drug in nearly 20 years has received approval from the Food and Drug Administration.

President Biden’s administration plans to donate 500 million coronavirus vaccine doses produced by Pfizer Inc. to the rest of the world, according to people familiar with the plans.

Federal regulators have approved the first new drug for Alzheimer’s disease in nearly 20 years, leaving patients waiting to see how insurers will handle the pricey new treatment.

Biogen Inc. shares were on track for their biggest gain on record after the drugmaker released pricing for its recently approved Alzheimer’s drug Aduhelm.

A new study from the New England Journal of Medicine found that Lynparza, a breast cancer medication, lead to a decrease in death and recurrence of breast cancer. Professor and Fox News medical contributor Dr. Marty Makary told Maria Bartiromo the development is “good news."